Supply Chain

Atlanta-based Logility recently launched the Logility Voyager Integrated Business Planning technology platform.

Mylan reached a $465 million settlement with the federal government over accusations the Canonsburg, Pa.-based drugmaker improperly classified EpiPens as a generic drug to overcharge Medicaid, reports The New York Times.

Clever Culture Systems earned Food and Drug Administration approval for its Automated Plate Assessment System.

Intellipharmaceutics International earned tentative approval from the Food and Drug Administration for its quetiapine fumarate tablets.

The Food and Drug Administration recently approved Deerfield, Ill.-based Lundbeck's new epilepsy drug Carnexiv.

While logistics companies, warehouses and courier services all added new positions last month in preparation for a busy holiday season, trucking companies and manufacturers slashed jobs due to slow growth in shipping volumes, reports The Wall Street Journal.

Our nation’s health systems remain focused on evolving in the face of change.

How 3PLs help hospitals and IDNs implement high value global sourcing programs

Ambulatory surgery center leaders face the challenge of reducing costs while increasing patient volume and offering high-quality service.

Dana-Farber Cancer Institute and Brigham and Women's Hospital, both in Boston, report extremely low supplies of available blood platelets, according to Boston Magazine.